Rawalpindi: BF Biosciences Limited has announced its Annual General Meeting (AGM) to be held on Wednesday, 28 October 2026, at 12:15 P.M. The meeting will take place at Blue Lagoon, Masood Akhter Kiani Road, Rawalpindi, with an option for members to join via video link.

The agenda for the AGM includes several key business items. Members will first confirm the minutes from the previous AGM held on 25 October 2025. Subsequently, they will receive, consider, and adopt the audited financial statements for the fiscal year ending 30 June 2026. These financial statements are accompanied by the Chairman's Review, Directors', and Auditors' reports.

The AGM will also address the appointment of auditors for the year ending 30 June 2027 and the determination of their remuneration. Additionally, a significant focus will be on special business, specifically the consideration and approval of related party transactions conducted during the financial year 2025-26.

The shareholders will be asked to ratify and confirm these transactions as disclosed in note 36 of the financial statements for the year ended 30 June 2026. Furthermore, the Board of Directors will seek authorization to approve any future related party transactions deemed appropriate.

In the context of the Pakistan Stock Exchange (PSX), BF Biosciences Limited falls within the designated market category. According to information available from the Pakistan Stock Exchange (PSX), this AGM represents a critical opportunity for the company to align its financial and operational strategies with shareholder interests.

The meeting will conclude with the transaction of any other business with the permission of the chair.